M&A Deal Summary

Trifoil Imaging Acquires Bioscan

On September 3, 2013, Trifoil Imaging acquired medical products company Bioscan

Acquisition Highlights
  • This is Trifoil Imaging’s 1st transaction in the Medical Products sector.
  • This is Trifoil Imaging’s 1st transaction in the United States.
  • This is Trifoil Imaging’s 1st transaction in District of Columbia.

M&A Deal Summary

Date 2013-09-03
Target Bioscan
Sector Medical Products
Buyer(s) Trifoil Imaging
Deal Type Add-on Acquisition
Advisor(s) Outcome Capital (Financial)

Target

Bioscan

Washington, District of Columbia, United States
Bioscan is a developer of equipment for the molecular imaging market including NanoSPECT, one of the most advanced preclinical imaging systems in the market. Its products are used in nuclear medicine, drug development, and research into body chemistry and disease causation, as well as in the development of new radio-pharmaceuticals for nuclear medicine applications.

Search 214,877 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Trifoil Imaging

Northridge, California, United States

Category Company
Sector Healthcare Services
DESCRIPTION

Trifoil Imaging, Inc. is a leading research laboratories around the world depend on TriFoil Imaging (formerly Gamma Medica Ideas Pre-Clinical) technology to meet all their advanced in-vivo molecular imaging needs.


DEAL STATS #
Overall 1 of 1
Sector: Medical Products M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: District of Columbia M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2013 M&A 1 of 1